Publication Date
8-1-2023
Journal
Redox Biology
DOI
10.1016/j.redox.2023.102790
PMID
37348155
PMCID
PMC10271936
PubMedCentral® Posted Date
6-16-2023
PubMedCentral® Full Text Version
Post-print
Published Open-Access
yes
Keywords
Humans, Infant, Newborn, Animals, Mice, Hyperoxia, Cytochrome P-450 CYP1A2, Lung Injury, Cytochrome P-450 CYP1A1, Mice, Inbred C57BL, COVID-19, Oxygen, Bronchopulmonary Dysplasia, Mice, Knockout, Lung, Animals, Newborn, Hyperoxia, Cytochrome P450, CYP1B1, Bronchopulmonary dysplasia, Lung, Oxidative stress
Abstract
Oxygen supplementation is life saving for premature infants and for COVID-19 patients but can induce long-term pulmonary injury by triggering inflammation, with xenobiotic-metabolizing CYP enzymes playing a critical role. Murine studies showed that CYP1B1 enhances, while CYP1A1 and CYP1A2 protect from, hyperoxic lung injury. In this study we tested the hypothesis that Cyp1b1-null mice would revert hyperoxia-induced transcriptomic changes observed in WT mice at the transcript and pathway level. Wild type (WT) C57BL/6J and Cyp1b1-null mice aged 8-10 weeks were maintained in room air (21% O
Graphical Abstract
Included in
Biological Phenomena, Cell Phenomena, and Immunity Commons, Life Sciences Commons, Medical Cell Biology Commons, Medical Microbiology Commons, Medical Molecular Biology Commons, Medical Specialties Commons
Comments
Associated Data